Ketamine also has come under increasing scrutiny as a treatment recently, with studies suggesting that for some patients it ...
El Mundo on MSN19h
US approves a new painkiller with less risk of addiction than opioids and equally potentThe suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...
In recent years, the wellness industry has seen a significant rise in the popularity of CBD products. Peak Naturals CBD ...
Joint health is a critical aspect of overall wellness that is often overlooked until discomfort arises. As we age, the wear ...
Patients and family members accuse Yale and YNHH of failing to relieve pain for ICU patients. The lawsuit comes half a year ...
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
While unfortunately, the same state's Department of Health reports their flu rates have reportedly increased 90% week-over-week.
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...
One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...
When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback